Mehraboon Irani of Nirmal Bang Securities told CNBC-TV18, "We have been quite positive on Camlin Fine Sciences for a long time. The stock split took place at Rs 2 and it became Re 1, the stock is around Rs 69, we have a target of Rs 100 for the stock. The company is into antioxidants which is mainly used in the food industry and what is positive for this company is that they have scaled up the capacity and the product mix is going to lead to an improvement in margins as well as revenues."
"We are looking at earnings of Rs 4.2 this year for a Re 1 face value which should be at least Rs 7.5 next year. A valuation of Rs 15 gives a target of around Rs 105-110 over the next 12 months," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!